VOLUME 63   2002   SUPPLEMENT 1

ARTICLES

3 Overview of Psychiatric Disorders and the Role of Newer Antidepressants. The Course of Major Depressive Disorder. Dennis S. Charney, Dale R. Grothe, and Sherry L. Smith
[PDF]

Major Depressive Disorder With Anxiety Symptoms or Sleep Disturbance. Kathleen T. Brady and Juliana Kaltsounis-Puckett
[PDF]

Antidepressant Selection: Focus on Nefazodone. Clinton W. Wright, Lyle K. Laird, and A. John Rush
[PDF]

10 Pharmacology of Antidepressants: Focus on Nefazodone. C. Lindsay DeVane, Dale R. Grothe, and Sherry L. Smith
[Abstract] [PDF]

18 Clinical Use of Nefazodone in Major Depression: A 6-Year Perspective. Use of Nefazodone in Major Depression. Alan F. Schatzberg and Maureen R. Prather Efficacy of Nefazodone in Chronic Depression. Martin B. Keller
[PDF]

Effects of Antidepressants on Sleep: Focus on Nefazodone. A. John Rush, Lyle K. Laird, and Clinton W. Wright
[PDF]

32 Six-Year Perspectives on the Safety and Tolerability of Nefazodone. Comparative Safety and Tolerability of Nefazodone. David L. Dunner and Lyle K. Laird
[PDF]

Nefazodone: Discontinuation Issues and Safety in Chronic Major Depression. John Zajecka and LaGenia Bailey
[PDF]

Effects of Nefazodone on Body Weight. Norman Sussman and Julia L. Seabolt
[PDF]

42 Antidepressant Dosing and Switching Guidelines: Focus on Nefazodone. John Zajecka, Geoffry W. McEnany, and Kimberly M. Lusk
[Abstract] [PDF]

48 Cost Savings With Nefazodone in Treating Depression. Robert E. Hales, Donald M. Hilty, and Gregory H. Brunson
[Abstract] [PDF]